Coagulation factor XI

Coagulation factor XI

Coagulation factor XI 詳細

Molecule Name
Coagulation factor XI
分子の別称
Coagulation factor XI,FXI,PTA,F11
Drug Development Progress
治験薬の数30
市販薬剤の数2
研究&開発段階Approved
ターゲットの別称
EC 3.4.21,EC:3.4.21.27,FXI,F11,PTA,Coagulation Factor XI,Plasma Thromboplastin Antecedent,EC 3.4.21.27,Factor XI,Coagualtion Factor XI
バックグランド
This protein is present in plasma as a zymogen, which is a unique plasma coagulation enzyme because it exists as a homodimer consisting of two identical polypeptide chains linked by disulfide bonds. During activation of the plasma factor XI, an internal peptide bond is cleaved by factor XIIa (or XII) in each of the two chains, resulting in activated factor XIa, a serine protease composed of two heavy and two light chains held together by disulfide bonds. This activated plasma factor XI triggers the middle phase of the intrisic pathway of blood coagulation by activating factor IX. Defects in this factor lead to Rosenthal syndrome, a blood coagulation abnormality

Coagulation factor XI 製品リスト

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
AsundexianBAY-2433334Phase 3 ClinicalBayer AG
Atrial Fibrillation; Embolism; Hepatic Insufficiency; Ischemic Attack, Transient; Ischemic Stroke; Myocardial Infarction; Stroke; Thromboembolism
詳細
CenvacibartREGN7508Phase 3 ClinicalRegeneron Pharmaceuticals Inc
Atrial Fibrillation; Peripheral Arterial Disease; Thrombosis; Venous Thromboembolism
詳細
MilvexianBMS-986177; JNJ-70033093; JNJ-3093Phase 3 ClinicalBristol-Myers Squibb Company
Acute Coronary Syndrome; Atrial Fibrillation; Contraception; Coronary Thrombosis; Embolism; Ischemic Attack, Transient; Ischemic Stroke; Kidney Failure, Chronic; Renal Insufficiency; Stroke; Thromboembolism; Thrombosis
詳細
SHR-2004SHR-2004Phase 3 ClinicalBeijing Suncadia Medicine Co Ltd
Arterial Thromboembolism; Atrial Fibrillation; Dyslipidemias; Thromboembolism; Thrombosis; Venous Thromboembolism; Venous Thrombosis
詳細
AmrecibartREGN-9933Phase 3 ClinicalRegeneron Pharmaceuticals Inc
Atrial Fibrillation; Peripheral Arterial Disease; Venous Thromboembolism
詳細
AbelacimabMAA-868; NOV-12Phase 3 ClinicalNovartis Pharma Ag
Atrial Fibrillation; Embolism; Neoplasms; Pulmonary Embolism; Stroke; Thromboembolism; Venous Thromboembolism; Venous Thrombosis
詳細
EP-7041EP-7041; HSK-36273Phase 2 ClinicalExithera Pharmaceuticals Inc
Blood Coagulation Disorders; Coronavirus Disease 2019 (COVID-19); Kidney Diseases; Thrombocytopenia; Thromboembolism; Thrombosis
詳細
OsocimabBAY-1213790Phase 2 ClinicalBayer AG
Kidney Diseases; Kidney Failure, Chronic; Thromboembolism
詳細
IONIS-FXIRXISIS-404071; BAY-2306001; ISIS-FXIRX; FXI-ASO; IONIS-FXIRX; ISIS-416858Phase 2 ClinicalIonis Pharmaceuticals Inc
Thrombosis; Venous Thromboembolism
詳細
MK-2060MK-2060Phase 2 ClinicalMerck Sharp & Dohme Corp
Kidney Diseases; Kidney Failure, Chronic; Thromboembolism; Thrombosis
詳細
SRSD-107SRSD-107; SRSD107Phase 2 ClinicalSirius Therapeutics Inc
Arterial Thromboembolism; Cardiovascular Diseases; Coronary Artery Disease; Coronary Disease; Peripheral Arterial Disease; Thromboembolism; Thrombosis; Venous Thromboembolism
詳細
RBD-4059RBD-4059; RBD4059; SR059; SR-059Phase 2 ClinicalSuzhou Ribo Life Science Co Ltd
Coronary Artery Disease; Coronary Disease; Kidney Failure, Chronic; Venous Thrombosis
詳細
KN-060KN-060; KN060Phase 2 ClinicalSuzhou Alphamab Co Ltd
Essential Hypertension; Hypertension; Kidney Failure, Chronic; Obesity; Overweight; Thromboembolism
詳細
Ir-CPIBIOX-101; Ir-CPIPhase 2 ClinicalFree University Of Brussels
Cerebral Hemorrhage
詳細
FesomersenION-957943; IONIS-FXI-LRx; BAY-2976217Phase 2 ClinicalIonis Pharmaceuticals Inc
Nephrosis; Thromboembolism
詳細
ONO-7269ONO-7269Phase 1 ClinicalOno Pharmaceutical Co Ltd
Cerebral Infarction
詳細
BAY-1831865AB-012; BAY-1831865Phase 1 ClinicalAronora Inc
Thrombosis
詳細
A-336A336; A-336Phase 1 ClinicalKlus Pharma
Thromboembolism
詳細
A-186A-186Phase 1 ClinicalSichuan Kelun Pharmaceutical Co Ltd
Thromboembolism
詳細
BMS-262084BMS-262084Phase 1 ClinicalBristol-Myers Squibb Company
Thrombosis
詳細
ADX-626ADX-626Phase 1 ClinicalADARx Pharmaceuticals Inc
Thrombosis
詳細
SBK-013SBK013; SBK-013Phase 1 ClinicalChengdu Shibeikang Biomedical Technology Co Ltd
Arterial Thromboembolism; Thromboembolism; Venous Thromboembolism
詳細
XH-S002XH-S002; XHS002Phase 1 Clinical
Ischemic Attack, Transient; Stroke
詳細
BMS-986209BMS-986209Phase 1 ClinicalBristol-Myers Squibb Company
詳細
NIP-003NIP003; NIP-003; CRB4101; CRB-4101Phase 1 ClinicalNational Institutes Of Pharmaceutical Research And Development Co Ltd
Thromboembolism; Venous Thromboembolism; Venous Thrombosis
詳細
Factor XIa Inhibitor (Bayer)Factor XIa Inhibitor (Bayer)Phase 1 ClinicalBayer AG
Blood Coagulation Disorders
詳細
SKB-336SKB-336Phase 1 ClinicalSichuan Kelun-Biotech Biopharmaceutical Co Ltd
Embolism; Thromboembolism
詳細
SAL-0104SAL-0104; SAL0104Phase 1 ClinicalSuzhou Genemen Biotech Co Ltd
Cardiovascular Diseases; Embolism; Ischemic Attack, Transient; Myocardial Infarction; Stroke; Thrombosis; Venous Thromboembolism; Venous Thrombosis
詳細
STP122GSTP-122G; STP122GPhase 1 ClinicalSirnaomics Biopharmaceuticals (Suzhou) Co Ltd
Embolism and Thrombosis
詳細
SHR2285SHR-2285Phase 1 ClinicalJiangsu Hengrui Medicine Co Ltd
Embolism; Thromboembolism; Thrombosis; Venous Thromboembolism
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
Factor XI concentrate (factor XI deficiency), CSL BehringApprovedCsl Behring LlcAustraliaFactor XI DeficiencyCsl Behring Llc2014-07-01
Factor XI Deficiency
詳細
Human coagulation Factor XI (LFB)ApprovedLfb Biotechnologies SasHemolevenEUFactor XI DeficiencyLfb Biotechnologies Sas1999-07-01
Factor XI Deficiency
詳細